Safety and Tolerability of RNS60 Given by IV to Healthy Subjects



Status:Archived
Conditions:Cardiology
Therapuetic Areas:Cardiology / Vascular Diseases
Healthy:No
Age Range:Any
Updated:7/1/2011
Start Date:April 2011
End Date:June 2011

Use our guide to learn which trials are right for you!

Trial Summary
Trial Overview
Inclusion Criteria

Phase I, Double-blind, Randomized, Placebo-controlled, Single-center Study to Assess the Safety and Tolerability of RNS60 Administered Intravenously to Healthy Subjects


The objective of this study is to evaluate the safety and tolerability of RNS60 administered
intravenously to healthy subjects. 12 subjects will receive RNS60 or placebo at three
escalating rates for 48 hours for each rate.



We found this trial at
1
site
Quintiles, Inc.
Overland Park, Kansas 66211
?
mi
from
Overland Park, KS
Click here to add this to my saved trials